• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection

tetano

Editor, Senior Moderator
Oncotarget. 2017 Mar 23. doi: 10.18632/oncotarget.16503. [Epub ahead of print]
[h=1]The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection.[/h] Zhang K[SUP]1,[/SUP][SUP]2[/SUP], Wei Xu W[SUP]1[/SUP], Zhang Z[SUP]1[/SUP], Liu J[SUP]1[/SUP], Li J[SUP]3[/SUP], Sun L[SUP]4[/SUP], Sun W[SUP]1[/SUP], Jiao P[SUP]5[/SUP], Sang X[SUP]1[/SUP], Ren Z[SUP]1[/SUP], Yu Z[SUP]1[/SUP], Li Y[SUP]1[/SUP], Feng N[SUP]1[/SUP], Wang T[SUP]1[/SUP], Wang H[SUP]1[/SUP], Yang S[SUP]1[/SUP], Zhao Y[SUP]1[/SUP], Zhang X[SUP]4[/SUP], Wilker PR[SUP]6[/SUP], Liu W[SUP]3[/SUP], Liao M[SUP]5[/SUP], Chen H[SUP]7[/SUP], Gao Y[SUP]1[/SUP], Xia X[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] H5N1 avian influenza viruses are a major pandemic concern. In contrast to the highly virulent phenotype of H5N1 in humans and many animal models, guinea pigs do not typically display signs of severe disease in response to H5N1 virus infection. Here, proteomic and transcriptional profiling were applied to identify host factors that account for the observed attenuation of A/Tiger/Harbin/01/2002 (H5N1) virulence in guinea pigs. RIG-I and numerous interferon stimulated genes were among host proteins with altered expression in guinea pig lungs during H5N1 infection. Overexpression of RIG-I or the RIG-I adaptor protein MAVS in guinea pig cell lines inhibited H5N1 replication. Endogenous GBP-1 expression was required for RIG-I mediated inhibition of viral replication upstream of the activity of MAVS. Furthermore, we show that guinea pig complement is involved in viral clearance, the regulation of inflammation, and cellular apoptosis during influenza virus infection of guinea pigs. This work uncovers features of the guinea pig innate immune response to influenza that may render guinea pigs resistant to highly pathogenic influenza viruses.


[h=4]KEYWORDS:[/h] GBP-1; RIG-I; guinea pig; highly pathogenic avian influenza virus; innate immunity

PMID: 28418930 DOI: 10.18632/oncotarget.16503
 
Back
Top Bottom